Technical Analysis for AKBA - Akebia Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bullish Engulfing | Bullish | 3.70% | |
Wide Bands | Range Expansion | 3.70% | |
Oversold Stochastic | Weakness | 3.70% | |
Wide Bands | Range Expansion | 8.74% | |
Oversold Stochastic | Weakness | 8.74% | |
Reversal New Lows Setup | Bearish Swing Setup | 4.67% | |
Wide Bands | Range Expansion | 4.67% |
Alert | Time |
---|---|
Rose Above Previous Day's High | 1 day ago |
60 Minute Opening Range Breakout | 1 day ago |
Up 5% | 1 day ago |
Up 3% | 2 days ago |
Up 2% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/06/2024
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.48 |
52 Week Low | 0.7801 |
Average Volume | 5,246,349 |
200-Day Moving Average | 1.30 |
50-Day Moving Average | 1.41 |
20-Day Moving Average | 1.20 |
10-Day Moving Average | 1.10 |
Average True Range | 0.10 |
RSI (14) | 40.83 |
ADX | 30.8 |
+DI | 15.33 |
-DI | 26.48 |
Chandelier Exit (Long, 3 ATRs) | 1.26 |
Chandelier Exit (Short, 3 ATRs) | 1.30 |
Upper Bollinger Bands | 1.46 |
Lower Bollinger Band | 0.95 |
Percent B (%b) | 0.34 |
BandWidth | 42.81 |
MACD Line | -0.09 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0011 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.24 | ||||
Resistance 3 (R3) | 1.24 | 1.19 | 1.22 | ||
Resistance 2 (R2) | 1.19 | 1.16 | 1.20 | 1.21 | |
Resistance 1 (R1) | 1.16 | 1.14 | 1.18 | 1.16 | 1.21 |
Pivot Point | 1.11 | 1.11 | 1.12 | 1.12 | 1.11 |
Support 1 (S1) | 1.08 | 1.08 | 1.10 | 1.08 | 1.03 |
Support 2 (S2) | 1.03 | 1.06 | 1.04 | 1.03 | |
Support 3 (S3) | 1.00 | 1.03 | 1.02 | ||
Support 4 (S4) | 1.00 |